English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Oxovanadium(IV) complexes of dibasic symmetrical bis-Schiff bases synthesized from 1,6-hexanediamine and orthohydroxy aldehydes or diketones. Their formation was confirmed with the help of elemental analysis, FTIR,  1 H NMR, UV-visible and mass spectra, magnetic susceptibility, and conductance measurements. Quantum mechanical calculations are indicative to the proposed structures of the complexes. Most of the ligands and complexes have considerable inhibition capacity on mycelia growth against selected pathogenic fungi and bacteria and show good antioxidant property too. Complexes showed good larvicidal activity against the mosquito larvae ( Culex quinquefasciatus ). Molecular docking of a Schiff base, (BzA-HD-BzAH 2 ) with SARS-CoV-2 Mpro revealed the best binding affinity with the receptor protein compared to the approved medicine hydroxychloroquine (HCQ) and favipiravir (FVP). The ADMET analysis showed that ligand is non-carcinogenic and less toxic than standards, HCQ or FVP. However, these  in silico  studies proved BzA-HD-BzAH 2  to be a good candidate for development as a therapeutic drug against SARS-CoV-2.

Synthesis, molecular modeling, and biomedical applications of oxovanadium(IV) complexes of Schiff bases as a good SARS-CoV-2 inhibitor